Advertisement
Screener

ENSYSCE BIOSCIENCES, INC. (ENSC) Form D

ENSYSCE BIOSCIENCES, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2025-04-25: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2025-04-23; Total offering amount $2,200,012.
  • 2025-04-14: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2025-03-31; Total offering amount $1,100,000.
  • 2024-09-12: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-08-29; Total offering amount $5,055,648.
  • 2024-02-21: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2024-02-14; Total offering amount $4,718,295.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2025-04-25Rule 506(b)OptionToAcquire2025-04-23$2,200,012$2,200,012$08
2025-04-14Rule 506(b)OptionToAcquire2025-03-31$1,100,000$1,100,000$08
2024-09-12Rule 506(b)OptionToAcquire; SecurityToBeAcquired2024-08-29$5,055,648$5,055,648$04
2024-02-21Rule 506(b)OptionToAcquire2024-02-14$4,718,295$4,718,295$04
2023-03-01Rule 506(b)OptionToAcquire; SecurityToBeAcquired2023-02-02$2,816,073$2,816,073$08
2022-07-08Rule 506(b)Debt; OptionToAcquire; SecurityToBeAcquired2022-06-30$8,480,000$4,240,000$4,240,0003
2021-10-06Rule 506(b)Debt; OptionToAcquire2021-09-24$15,900,000$5,300,000$10,600,0003

Similar stocks

Stock NameCountryMarket CapPE Ratio
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
SYNLOGIC, INC. (SYBX)United States$0.007B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26